/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,666.45
+0.19%
NASDAQ 100
$30,501.56
+0.31%
DOW JONES
$50,927.00
+0.04%
NASDAQ Composite
$26,871.60
+0.04%
RUSSELL 2000
$2,790.20
+0.41%
CBOE VIX
$16.39
+0.31%

Sector Heatmap

Technology+1.05%
Financials+0.11%
Healthcare-1.32%
Consumer Cycl-0.03%
Consumer Staples-0.33%
Energy+1.95%
Industrials+0.99%
Materials-0.33%
Real Estate-0.56%
Utilities+0.61%
Comm Services-0.93%

ALNY — Alnylam Pharmaceuticals, Inc.

Nasdaq

Alnylam Pharmaceuticals, Inc.

Back to Screener
$231.04
-15.70(-6.36%)
O
248.21
H
251.71
L
230.06
V
2.01M
⏱️ End-of-day dataAs of Oct 1, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Alnylam Pharmaceuticals, Inc. Statistics

Total Valuation

Market Cap$34.25B
Enterprise Value$34.20B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding133.81M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio153.01
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio288.80
P/TBV Ration/a
P/FCF Ratio703.70
P/OCF Ratio445.80
PEG Ration/a

Enterprise Valuation

EV / Earnings1,660.34
EV / Salesn/a
EV / EBITDA1,123.23
EV / EBIT1,175.55
EV / FCF702.71

Financial Position

Current Ratio3.13
Quick Ration/a
Debt / Equity1.14
Debt / EBITDA4.03
Debt / FCF2.52
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)19.16%
Return on Assets (ROA)4.02%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$8,240
Employee Count2,500
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$15.66M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-49.84%
50-Day Moving Average$242.47
200-Day Moving Average$303.74
Relative Strength Index (RSI)38.67
Average Volume (20 Days)1,377,375

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$95.61M
Operating Income$26.86M
Pretax Income$22.17M
Net Income$20.60M
EBITDA$30.45M
EBIT$29.09M
Earnings Per Share$1.51

Balance Sheet

Cash & Cash Equivalents$171.08M
Total Debt$122.74M
Net Cash$48.34M
Net Cash Per Share$0.36
Equity (Book Value)$107.54M
Book Value Per Share$0.80
Working Capital$286.98M

Cash Flow

Operating Cash Flow$76.83M
Capital Expenditures-$21.83M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$48.67M
FCF Per Share$0.36

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.65%
FCF Yield0.14%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$22.65
Lynch Upside-90.20%
Graham Number$5.21
Graham Upside-97.74%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a